Table 4 Adverse events and serious adverse events
Number of subjects (% of treatment group) | 100 mg IV Ibuprofen | 200 mg IV Ibuprofen | 400 mg IV Ibuprofen | Placebo | ||||
|---|---|---|---|---|---|---|---|---|
Subjects experiencing no AEs | 4 | 13% | 5 | 17% | 8 | 26% | 3 | 11% |
Subjects experiencing any AEs (including SAEs) | 27 | 87% | 25 | 83% | 23 | 74% | 25 | 89% |
Subjects experiencing SAEs (including death) | 6 | 19% | 5 | 17% | 4 | 13% | 4 | 14% |
Patient deaths | 1 | 3% | 2 | 7% | 2 | 6% | 1 | 4% |
Total subjects | 31 | 30 | 31 | 28 | ||||